impf-info.de
Nachdem Covid19 aus medizinischer Sicht "durch" ist, hier jetzt also wieder das Thema Impfen in ganzer Breite...
Borreliose: Impfstoff-Studie von Pfizer/Valneva halbiert plötzlich die Teilnehmerzahl - mögliche Gefährdung der Zulassung
Pfizer, Valneva to stop testing Lyme disease vaccine in some U.S. patients | Reuters
Drugmaker Pfizer Inc and France's Valneva will stop testing a Lyme disease vaccine in roughly half of U.S. patients in a late-stage study, the companies said, citing a breach of clinical trial guidelines by a third-party contractor.
By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/
